Mystery Case: A 21-Year-Old Man with Visual Loss Following Marijuana Use
Neurol 84:e165-e169, Whitlock, J.B.,et al, 2015
Prevalence of Fabry Disease in Patients with Cryptogenic Stroke: A Prospective Study
Lancet 366:1794-1796,1754, Rolfs,A.,et al, 2006
Risk of Cerebral Sinus Thrombosis in Oral Contraceptive Users Who Are Carriers of Hered Prothrombotic Cond
BMJ 316:589-592, deBruijn,S.F.T.M.,et al, 1998
High Risk of Cerebral-Vein Thromb in Carriers of Prothrombin-Gene Mutation & Users of Oral Contracept
NEJM 338:1793-1797, 18401998., Martinelli,I.,et al, 1998
Cerebral Infarction in Young People, A Study of 148 Patients with Early Cerebral Angiography
JNNP 54:576-579, Lisovoski,F.&Rousseaux,P., 1991
Nonatherosclerotic Causes of Stroke
Ann Int Med 70:807, Levine,J.,et al, 1969
Clinicopathologic Conference, Reversible Cerebral Vasoconstriction Syndrome with Takotsubo Cardiomyopathy
NEJM 390:2108-2118, Case 18-2024, 2024
Genetic Causes of Cerebral Small Vessel Diseases, A Parctical Guide for Neurologists
Neurol 100:766-783, Manini,A.,&Pantoni,L., 2023
Clinicopathologic Conference, Antiphospholipid Syndrome due to SLE with Hypocomplimentemia
NEJM 389: 2277-2285, Case 38-2023, 2023
Oral Contraceptives, Hormone Replacement Therapy, and Stroke Risk
Stroke 53:3107-3115, Johansson, T.et al, 2022
Updates on Sturge-Weber Syndrome
Stroke 53:3769-3779, Yeom,S.E.&Comi,A.M., 2022
Drugs Associated with Ischemic Stroke
Stroke 52:e646-e659, Marto, J.P.,et al, 2021
A young woman with symmetric weakness and behavioral disturbance
Neurol 90:e1442-e1447, Rosenberg, J.,et al, 2018
A 77-year-old man presenting with episodic expressive aphasia
Neurol 90:e1822-e1826, Shanklin, A.,et al, 2018
Diagnosis and Management of the Antiphospholipid Syndrome
NEJM 378:2010-2021, Garcia, D. & Erkan, D., 2018
Clinicopathologic Conference, Poststroke Mania and the Frontal Lobe Syndrome
NEJM 379:182-189, Case 21-2018, 2018
Pregnancy, Hormonal Treatments for Infertility, Contraception, and Menopause in Women After Ischemic Stroke
Stroke 48:501-506, Caso, V.,et al, 2017
Primary Angiitis of the Central Nervous System
Stroke 48:1248-1255, Boulouis, G.,et al, 2017
Clinicopathologic Conference, Paroxysmal Nocturnal Hemoglobinuria
NEJM 377:2581-2590, Case 40-2017, 2017
Clinicopathologic Conference, Homocystinuria caused by Cystathionine B-Synthase Deficiency
NEJM 375:1879-1890, Case 34-2016, 2016
Chronic Hepatitis C Virus Infection and Neurological and Psychiatric Disorders
World J Gastroenterol 21:2269-2280, Adinolfi, L.E.,et al, 2015
Prevention Opportunities for Oral Contraceptive-Associated Ischemic Stroke
Stroke 45:893-895, Ryan, K.A.,et al, 2014
Early-Onset Stroke and Vasculopathy Associated with Mutations in ADA2
NEJM 370:911-920, Zhou, Q.,et al, 2014
Polycythemia Vera Presenting with Ischemic Strokes in Multiple Arterial Territories
Neurol 82:e168-e170, Billakota, S. & Husseini, N.E., 2014
Clinicopathologic Conference, Susacs Syndrome (retinocochleocerebral vasculopathy)
NEJM 365:549-559, Case 24-2011, 2011
Infectious and Non-Infectious Neurologic Complications in Heart Transplant Recipients
Medicine 89:166-175, Mu�oz,P., et al, 2010
Clinical Spectrum of CADASIL and the Effect of Cardiovascular Risk Factors on Phenotype: Study in 200 Consecutively Recruited Individuals
Stroke 41:630-634, Adib-Samii,P., et al, 2010
Pathophysiology of Thrombotic Thrombocytopenic Purpura
Int J Hematol 91:1-30, Tsai, H.M., 2010
Stroke in Women: An Evolving Topic
Stroke 40:1027-1028, Kurth,T. &Bousser,M.-G., 2009
Clinicopath Conf, Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL)
NEJM 360:1656-1665, Case 12-2009, 2009
Brain Lesions Are Most Often Reversible in Acute Thrombotic Thrombocytopenic Purpura
Neurol 73:66-70, Burrus,T.M.,et al, 2009
Migraine and Cardiovascular Disease: Systematic Review and Meta-Analysis
BMJ 339:b3914, Sch�rks,M.,et al, 2009
Bilateral Thalamic Lesions
AJR 192:W53-W62, Smith,A.B.,et al, 2009
May-Thurner Syndrome in Patients with Cryptogenic Stroke and Patent Foramen Ovale
Stroke 40:1502-1504, Kiernan, T.J.,et al, 2009
Emergency Administration of Abciximab for Treatment of Patients With Acute Ischemic Stoke: Results of an International Phase III Trial: Abciximab in Emergency Treatment of Stroke Trial (AbESTT-II)
Stroke 39:89-99, Adams,H.P.,Jr.,et al, 2008
Investigating Suspected Cerebral Venous Thrombosis
BMJ 334:794-795, Smit,R. &Hourihan,M.D., 2007
Differential Diagnosis of Bilateral Thalamic Lesions
Clin Neuroradiol 17:3-22, Linn,J.,et al, 2007
The Thalamus and Behavior. Effects of Anatomically Distinct Strokes
Neurol 66:1817-1823, Carrera,E. &Bogousslavsky,., 2006
Central Nervous System Injury Associated with Cardiac Surgery
Lancet 368:694-703, Newman,M.F.,et al, 2006
Thrombosis of the Cerebral VEins and Sinuses
NEJM 352:1791-1798, Stam,J., 2005
Folate, Vitamin B12, and Risk of Ischemic and Hemorrhagic Stroke
Stroke 36:1426-1431, Guelpen,B.V.,et al, 2005
Protein S Deficiency in HIV Associated Ischaemic Stroke:An Epiphenomenon of HIV Infection
JNNP 76:1455-1456,1331, Mochan,A.,et al, 2005
Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy (CADASIL)
Pract Neurology 4:50-55, Razvi,S.S.M. &Muir,K.W., 2004
Risk of Ischemic Stroke Among Users of the Oral Contraceptive Pill
Stroke 34:1575-1580, Siritho,S.,et al, 2003
Homocysteine, Silent Brain Infarcts, and White Matter Lesions: The Rotterdam Scan Study
Ann Neurol 51:285-289,279, Vermeer,S.E.,et al, 2002
Prospective Assessment of Risk Factors for Recurrent Stroke During Childhood--A 5-year Follow-up Study
Lancet 360:1540-1545,1526, Strater,R.,et al, 2002
A Practical Approach to the Diagnosis and Management of MELAS: Case Report and Review
The Neurologist 8:302-312, Thambisetty,M.,et al, 2002
Use of Specialized Coagulation Testing in the Evaluation of Patients with Acute Ischemic Stroke
Neurol 56:624-627, Bushnell,C.,et al, 2001
Vitamin D Deficiency and Risk of Hip Fractures Among Disabled Elderly Stroke Patients
Stroke 32:1673-1677, Sato,Y.,et al, 2001